Age at transplant (years), median (range) |
10.6 (0.3-20.0) |
8 (1.7-11.7) |
Female, # (%) |
6 (33) |
5 (50) |
Race/Ethnicity, n (%) |
White, Non-Hispanic |
13 (72) |
6 (60) |
African-American |
- |
1 (10) |
Hispanic |
5 (28) |
1 (10) |
Middle Eastern |
- |
2 (20) |
Disease, n (%) |
Severe Aplastic Anemia (SAA) |
Idiopathic |
9 (50) |
3 (30) |
SAA with >10% PNH |
1 (6) |
- |
Hepatitis associated |
2 (11) |
4 (40) |
Diamond-Blackfan Anemia |
1 (6) |
1 (10) |
Severe Congenital Neutropenia |
4 (22) |
1 (10) |
Congenital Sideroblastic Anemia |
- |
1 (10) |
Amegakaryocytic Thrombocytopenia |
1 (6) |
- |
Time from diagnosis to SCT (years), median (range) |
0.2 (0.1 to 15) |
0.2 (0.1 to 9.1) |
More than 10 lifetime PRBC transfusions pre-SCT |
1 (6) |
2 (20) |
Prior treatments n (%) |
1 (6) |
- |
IST for aplastic anemia (hATG/CSA) Steroids for hepatitis/DBA |
2 (11) |
4 (40) |
Chronic RBC/platelet Transfusions |
2 (11) |
1 (10) |
Chronic G-CSF |
4 (22) |
1 (10) |